BIOCOM for BIOCOM
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Nov 17, 2020 | $45,000 | Replaced |
| 3rd Quarter - Amendment | Nov 17, 2020 | $45,000 | Yes |
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Advocated for additional funding for NIH and BARDA in FY2021 appropriations and coronavirus supplemental legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Labor Issues/Antitrust/Workplace LBR
Advocated for targeted and temporary liability protections for life science organizations
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Copyright/Patent/Trademark CPT
Expressed support for the Bayh-Dole Act, as part of the law's 40th anniversary campaign
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Health Issues HCR
Sent information to House and Senate staff about the life science's industry response to covid-19. Sent comments to the HELP Committee re "Preparing for the Next Pandemic" white paper. Expressed support for the coverage of home infusion of Medicare Part B drugs during the covid-19 pandemic. Advocated for the exemption of life science research facilities from stay-at-home orders Expressed position on and challenges with domesticating the US drug supply chain Expressed support for expanding telehealth services Expressed support for policies that encourage the use and development of novel antibiotics to fight anti-microbial resistance (AMR)
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Small Business SMB
Advocated for additional funding for the Paycheck Protection Program (PPP), which had run out of funding Urged the US Treasury Department and SBA to clarify that small businesses with equity investors will be eligible for the small business loan program created by the CARES Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Immigration IMM
Expressed concerns with proposals that would restrict visas for international students, researchers and faculty as the country reopens
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.